Amgen (NASDAQ:AMGN) today announced the first clinical results from studies evaluating investigational novel bispecific T cell engager (BiTE®) immunotherapies AMG 420 and AMG 330. In two separate...

Ascentage Pharma, a clinical-stage biopharmaceutical company dedicated to the development of novel therapies for the treatment of cancers, hepatitis B and aging-related diseases, today announced...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer, today...

Today, FORTUNE announced more than 30 global business and design leaders who will participate in 2019 Brainstorm Design, scheduled to occur during Singapore Design Week on March 5-7 2019....

From Thursday, November 1st through Saturday, November 3rd, Heartland Dental hosted over 125 supported dentists and 70 dental assistants at the Company's first-annual Implant Continuum, an...